title: Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.
abstract: Interleukin-35 (IL-35) has been reported to inhibit the production of interleukin-17 (IL-17) as a means of preventing arthritis and other inflammatory diseases. We previously showed that treatment of Borrelia-vaccinated and -infected mice with anti-IL-17 antibody at the time of infection prevented the development of arthritis. The anti-IL-17 antibody-treated mice lacked the extensive tissue damage, such as bone and cartilage erosion, that occurred in the tibiotarsal joints of untreated Borrelia-vaccinated and -infected control mice. We hypothesized that IL-35 would reduce the severity of arthritis by suppressing the production of IL-17 in Borrelia-vaccinated and -infected mice. Here, we show that administration of recombinant IL-35 (rIL-35) to Borrelia-vaccinated and -infected mice augments the development of severe arthritis compared to the results seen with untreated control mice. Borrelia-vaccinated and -infected mice treated with rIL-35 had significantly (P < 0.05) greater hind paw swelling and histopathological changes from day 4 through day 10 than non-rIL-35-treated Borrelia-vaccinated and -infected mice. In addition, the treatment with IL-35 only slightly decreased the production of IL-17 in Borrelia-primed immune cells and did not prevent the development of borreliacidal antibody. Our data do not support a role for IL-35 as a potential therapeutic agent to reduce inflammation in Lyme arthritis.
authors: Wisconsin State Laboratory of Hygiene, 465 Henry Mall, Madison, WI 53706, USA.
authors: Joseph
authors: J
authors: Kuo
authors: Dean T
authors: DT
authors: Nardelli
authors: Thomas F
authors: TF
authors: Warner
authors: Steven M
authors: SM
authors: Callister
authors: Ronald F
authors: RF
authors: Schell
references: Infect Immun. 1995 Apr;63(4):1400-8
references: 7890402
references: J Autoimmun. 2004 Nov;23(3):281-92
references: 15501399
references: N Engl J Med. 1983 Mar 31;308(13):733-40
references: 6828118
references: FEMS Immunol Med Microbiol. 2008 Jul;53(2):265-74
references: 18522647
references: J Immunol. 2000 Dec 1;165(11):6107-15
references: 11086043
references: FEMS Immunol Med Microbiol. 2008 Jan;52(1):124-33
references: 18081848
references: Clin Diagn Lab Immunol. 1996 Jul;3(4):399-402
references: 8807203
references: J Immunol. 2003 Dec 1;171(11):6173-7
references: 14634133
references: Science. 1998 Jul 31;281(5377):703-6
references: 9685265
references: Nature. 2006 May 11;441(7090):235-8
references: 16648838
references: Ann Intern Med. 1987 Nov;107(5):725-31
references: 3662285
references: Curr Probl Dermatol. 2009;37:31-50
references: 19367096
references: J Immunol. 2000 Jun 15;164(12):6096-9
references: 10843657
references: Clin Vaccine Immunol. 2006 Feb;13(2):289-96
references: 16467340
references: Infect Immun. 2003 Jun;71(6):3437-42
references: 12761128
references: Infect Immun. 2000 Feb;68(2):658-63
references: 10639430
references: FEMS Immunol Med Microbiol. 2010 Oct;60(1):78-89
references: 20662925
references: Ann N Y Acad Sci. 2010 Jan;1183:211-21
references: 20146717
references: FEMS Immunol Med Microbiol. 2007 Apr;49(3):353-63
references: 17378899
references: Clin Vaccine Immunol. 2008 Aug;15(8):1199-207
references: 18579699
references: Clin Diagn Lab Immunol. 2005 Jun;12(6):786-92
references: 15939755
references: Infect Immun. 1995 Dec;63(12):4818-25
references: 7591141
references: Clin Diagn Lab Immunol. 2004 Nov;11(6):1075-84
references: 15539509
references: Am J Trop Med Hyg. 1992 Nov;47(5):605-13
references: 1449201
references: Eur J Immunol. 2007 Nov;37(11):3021-9
references: 17874423
references: Arthritis Rheum. 2008 Nov;58(11):3609-17
references: 18975343
references: J Exp Med. 1991 Sep 1;174(3):593-601
references: 1831490
references: Arthritis Rheum. 1999 Sep;42(9):1813-22
references: 10513794
references: Clin Diagn Lab Immunol. 2003 Jan;10(1):44-52
references: 12522038
references: Clin Diagn Lab Immunol. 1994 Jan;1(1):44-50
references: 7496920
references: J Exp Med. 1994 Dec 1;180(6):2069-78
references: 7964484
references: Clin Vaccine Immunol. 2009 Feb;16(2):253-9
references: 19052162
references: J Immunol. 2010 Jun 15;184(12):7144-53
references: 20483737
references: J Immunol. 1998 Jan 15;160(2):1022-8
references: 9551943
references: Infect Immun. 1999 Jul;67(7):3329-33
references: 10377109
references: J Immunol. 1997 May 15;158(10):4838-45
references: 9144499
references: Nature. 2007 Nov 22;450(7169):566-9
references: 18033300
references: Eur J Immunol. 2011 Jan;41(1):172-81
references: 21182088
references: Infect Immun. 1999 Apr;67(4):1967-73
references: 10085044